Navigation Links
Pfizer's Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan
Date:10/28/2010

NEW YORK, Oct. 28 /PRNewswire-FirstCall/ -- Pfizer Inc.(NYSE: PFE) announced today that the Japanese Ministry of Health, Labour and Welfare approved Lyrica® (pregabalin) capsules for the treatment of peripheral neuropathic pain.  This follows the recent approval in Japan of Lyrica for the treatment of postherpetic neuralgia on April 16, 2010.  Lyrica is the first medication approved for peripheral neuropathic pain in Japan where it is co-promoted with Eisai Co., Ltd.

(Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO)

"Neuropathic pain remains an under-diagnosed condition in many parts of the world, in large part due to low awareness and understanding of the condition and the fact that there are few proven treatment options available," said Steve Romano, M.D., vice president, Medical Affairs Head, Primary Care Business Unit at Pfizer.  "This approval reinforces the benefit that Lyrica can bring to appropriate patients suffering from peripheral neuropathic pain."

Peripheral neuropathic pain, or peripheral nerve pain, is a difficult-to-treat chronic pain condition.  It is initiated or caused by a primary lesion or dysfunction in the peripheral nervous system.  The pain symptoms that patients experience are often described as burning, tingling or shock-like sensations. Peripheral neuropathic pain may be triggered by a variety of medical conditions including nerve injury, sciatica, fibromyalgia, diabetes, infection (herpes zoster), cancer, HIV infection and HIV treatment.  Research has shown that patients with neuropathic pain are often prescribed medications that have no demonstrated efficacy in treating this type of pain or have significant side effects.  

The Lyrica approval was based on ten Phase 3 double-blind studies including eight W
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
2. GSK Receives Approval for HYCAMTIN(R) (topotecan) Capsules for the Treatment of Relapsed Small Cell Lung Cancer
3. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
4. Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
5. Results Published In Journal of Cystic Fibrosis Confirm CREON(R) (pancrelipase) Delayed-Release Capsules Improves Fat Absorption in Patients With Cystic Fibrosis
6. CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis
7. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
8. CREON(R) (pancrelipase) Delayed-Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis
9. Shire Re-Launches FOCUS, an Online, Personalized Patient Support Program for Adults with ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII
10. Xanodyne Expands U.S. Sales Force and Launches Zipsor(TM) (diclofenac potassium) Liquid Filled Capsules
11. FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: ... immune therapies for operable and inoperable solid tumor cancers, announced ... the 7 th Annual Phacilitate Immunotherapy Forum in ... at Phacilitate will take place on January 26 at 10:30 ...
(Date:1/23/2015)... and DUBLIN , Jan. 23, 2015 ... with KRS Global Biotechnology, Inc. for the compounding, packaging and ... for shipment in the United States . ... Outsourcing Facility capable of compounding naltrexone tablets in various strengths ...
(Date:1/23/2015)... Fla. , Jan. 23, 2015  HyGreen, Inc., a ... agreement and partnership with RCA Medical, a subsidiary of ... . Each year, hundreds of millions ... care-associated infections as organisms are transmitted from patient to ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2
... Leaders to Introduce Legislation , WASHINGTON , ... Network (ACPCN) will join congressional leaders tomorrow to introduce ... Act." The bill by U.S. Rep. G.K. Butterfield ... (PBM) companies for medications. , "Congress is prepared to ...
... , WASHINGTON, Nov. 16 ... heath care retail clinic market has increased approximately 15 percent ... released today by the Deloitte Center for Health Solutions. Retail ... from 2010 through 2012 and will accelerate above 30 percent ...
Cached Medicine Technology:Pharmacists Work with Congress to Address PBM Abuses 2Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 2Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 3Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 4
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that can ... for those same twenty-plus years, the team at Doctors on ... the best possible doctor. With the combined breadth of ...
(Date:1/22/2015)... January 22, 2015 Yesterday, Senator ... (D-Concord) and Kristin Olsen (R-Modesto) were honored by ... in advancing biotechnology, biomedical science, medical device and ... each received the “2014 Life Sciences Champion” award ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... has released a new blog post presenting a list of vehicles ... , Some types of vehicles cannot be covered under an ... post to see if their vehicle qualifies for auto insurance coverage. ... the cars that cannot be covered by a plan. Clients have ...
(Date:12/26/2014)... The US represents the largest market for CRC across ... estimates that sales of branded therapies were $2.23 billion. The ... incidence of the disease, high drug treatment rate, and higher ... sales of CRC therapies over the forecast period will be ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... have engineered a way to deliver health-promoting nutrients using ... breakthrough could lead to low fat or non-fat foods ... and could be used to enrich foods with other ... ,The team, led by Dr. Yoav D. Livney of ...
... future of cancer detection and treatment may be in gold ... be seen by the naked eye.// The potential of gold ... in a stable, nontoxic form that can be injected into ... found that a plant extract can be used to overcome ...
... leading pharmaceutical companies, issued a press release that stated ... cancer. ,A Phase III clinical trial ... (mitoxantrone) plus prednisone. The study included a little over ... disease after hormonal therapy., ,The results of the ...
... Delhi: The incidence of malaria, one of the most common ... cases in 2005 to 1.2 million cases in 2006, the ... the social sectors, the Economic Survey said malaria deaths came ... this period. ,According to it, in some parts ...
... pounds should add daily walks and limit TV time and ... // ,“The childbearing years are a time of particular ... Oken, M.D. “Modifiable behaviors in that early postpartum period — ... a woman’s risk of retaining weight.” ,Oken and ...
... could have better success rates following surgery, thanks to ... ,The study was published in the February, 2007 issue ... journal of the American Academy of Otolaryngology-Head and Neck ... Otolaryngology, the study measured success rates of patching eardrum ...
Cached Medicine News:Health News:Natural Milk Protein Could Lead to Super Nutritious Foods 2Health News:Common Ingredient in Big Macs and Sodas Can Stabilize Gold Nanoparticles for Medical Use 2Health News:Common Ingredient in Big Macs and Sodas Can Stabilize Gold Nanoparticles for Medical Use 3Health News:Incidence of Malaria Has Come Down, Says Economic Survey 2Health News:Simple Solutions to Postpartum Weight Retention 2Health News:Inner-ear Volume Study Leads to Higher Surgery Success Rates 2
... system delivers cold air to the patient ... temperatures down to 10C. Cooling the body ... been used as a therapeutic tool, particularly ... hypothermia is now widely used as a ...
Complete Cataract Competence , OPMI VISU 140 is compact, good and economical. It's everything a cataract specialist needs today....
Whole blood tube use for microbiology...
MONOJECT Brown Stopper...
Medicine Products: